Effector and regulatory B cells in Multiple Sclerosis

Copyright © 2017 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 184(2017) vom: 10. Nov., Seite 11-25
Auteur principal: Staun-Ram, Elsebeth (Auteur)
Autres auteurs: Miller, Ariel
Format: Article en ligne
Langue:English
Publié: 2017
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Review Autoimmune B cells Bregs Immune-modulation Immunotherapy Multiple Sclerosis Crotonates Hydroxybutyrates plus... Immunologic Factors Immunosuppressive Agents Natalizumab Nitriles Toluidines teriflunomide 1C058IKG3B Alemtuzumab 3A189DH42V Rituximab 4F4X42SYQ6 Glatiramer Acetate 5M691HL4BO Interferon-beta 77238-31-4 Dimethyl Fumarate FO2303MNI2 Fingolimod Hydrochloride G926EC510T